SABCS: Tamoxifen, Anastrozole Both Prevent Recurrence in DCIS

Share this content:
SABCS: Tamoxifen, Anastrozole Both Prevent Recurrence in DCIS
SABCS: Tamoxifen, Anastrozole Both Prevent Recurrence in DCIS

FRIDAY, Dec. 11, 2015 (HealthDay News) -- Postmenopausal women with hormone receptor-positive ductal carcinoma in situ (DCIS) have similar recurrence rates of disease whether they take tamoxifen or the aromatase inhibitor anastrozole after surgery, according to findings scheduled to be presented at the annual San Antonio Breast Cancer Symposium, held from Dec. 8 to 12 in San Antonio.

Jack Cuzick, Ph.D., director of the Wolfson Institute of Preventive Medicine at Queen Mary University of London, and colleagues looked at 2,980 women, all postmenopausal, who had hormone receptor-positive DCIS breast cancer and underwent surgery to excise it. Half the women were randomly assigned to take 1 mg a day of anastrozole, while the other half took 20 mg a day of tamoxifen. Each group also took a placebo pill.

After a follow-up of about seven years, those who took anastrozole had an 11 percent lower breast cancer recurrence rate than those who took tamoxifen, but that difference was not statistically significant, Cuzick told HealthDay.

In a related study to be presented at the symposium, University of California, Los Angeles, researchers led by Patricia Ganz, M.D., found no difference in quality-of-life measures among women who took the two drugs after treatment for DCIS. But they did find the expected differences in side effects. Those patients on tamoxifen had more hot flashes, while those on anastrozole had more vaginal problems and muscle aches.

Press Release 1
Press Release 2
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

California Lawsuit Claims AbbVie Paid Doctors to Prescribe Humira

California Lawsuit Claims AbbVie Paid Doctors to Prescribe ...

Claims physicians prescribed Humira because of financial kickbacks, not as best drug for patient

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-controlled remifentanil reduces proportion of conversions versus intramuscular pethidine

Pediatricians Have Role in Supporting Transgender Youth

Pediatricians Have Role in Supporting Transgender Youth

Recommendations developed for comprehensive care for youth identifying as transgender, gender diverse

is free, fast, and customized just for you!




Already a member?

Sign In Now »